NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
This Quarter Return
+0.68%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$788M
AUM Growth
+$788M
(-4.4%)
Cap. Flow
-$23.9M
Cap. Flow
% of AUM
-3.04%
Top 10 Holdings %
Top 10 Hldgs %
45.27%
Holding
137
New
21
Increased
28
Reduced
38
Closed
17
Top Buys
| 1 |
Assertio
ASRT
|
$12M |
| 2 |
America's Car Mart
CRMT
|
$11.4M |
| 3 |
Zevra Therapeutics
ZVRA
|
$11.1M |
| 4 |
Peloton Interactive
PTON
|
$9.05M |
| 5 |
Neuropace
NPCE
|
$7.74M |
Top Sells
| 1 |
Dianthus Therapeutics
DNTH
|
$63.7M |
| 2 |
The Bancorp
TBBK
|
$13.2M |
| 3 |
AUTL
Autolus Therapeutics
AUTL
|
$10.2M |
| 4 |
Pathward Financial
CASH
|
$7.8M |
| 5 |
Soleno Therapeutics
SLNO
|
$7.6M |
Sector Composition
| 1 | Healthcare | 53.65% |
| 2 | Consumer Discretionary | 13.83% |
| 3 | Financials | 9.32% |
| 4 | Communication Services | 8.18% |
| 5 | Technology | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Establishment Labs
ESTA
$1.2B
| $92.6M | 7.91% | 1,887,617 +44,383 | +2% | +$2.18M |
|
|
2
Pathward Financial
CASH
$1.82B
| $56.9M | 4.86% | 1,234,526 -169,181 | -12% | -$7.8M |
|
3
IMAX
IMAX
$1.54B
| $50.4M | 4.3% | 2,606,884 -337,993 | -11% | -$6.53M |
|
4
Luxfer Holdings
LXFR
$359M
| $27.7M | 2.36% | 2,121,162 -102,277 | -5% | -$1.33M |
|
5
Red Violet
RDVT
$702M
| $25.3M | 2.16% | 1,261,896 -5,718 | -0.5% | -$114K |
|
6
Immatics
IMTX
$619M
| $22.2M | 1.9% | 1,920,636 -364,259 | -16% | -$4.22M |
|
|
7
America's Car Mart
CRMT
$371M
| $21M | 1.8% | 230,953 +124,775 | +118% | +$11.4M |
|
8
Hilton Grand Vacations
HGV
$4.24B
| $20.5M | 1.75% | 504,242 +63,363 | +14% | +$2.58M |
|
9
uniQure
QURE
$896M
| $20.3M | 1.73% | 3,023,799 +174,815 | +6% | +$1.17M |
|
10
Bioventus
BVS
$495M
| $19.9M | 1.7% | 6,018,532 +400,906 | +7% | +$1.32M |
|
|
11
Peloton Interactive
PTON
$3.1B
| $18M | 1.53% | 3,554,606 +1,792,295 | +102% | +$9.05M |
|
12
Lyra Therapeutics
LYRA
$11.5M
| $15.8M | 1.35% | 4,050,218 +92,676 | +2% | +$362K |
|
13
Viemed Healthcare
VMD
$286M
| $13.7M | 1.17% | 2,032,170 +303,675 | +18% | +$2.04M |
|
|
14
Assertio
ASRT
$80.4M
| $12M | 1.02% | +4,670,000 | New | +$12M |
|
|
15
Neuropace
NPCE
$303M
| $11.9M | 1.01% | 1,219,915 +795,065 | +187% | +$7.74M |
|
|
16
Soleno Therapeutics
SLNO
$3.6B
| $11.6M | 0.99% | 392,404 -257,437 | -40% | -$7.6M |
|
17
Golden Entertainment
GDEN
$651M
| $11.3M | 0.97% | 332,056 -7 | -0% | -$239 |
|
|
18
Zevra Therapeutics
ZVRA
$509M
| $11.1M | 0.95% | +2,308,216 | New | +$11.1M |
|
19
The RMR Group
RMR
$285M
| $10.6M | 0.9% | 432,033 -267,297 | -38% | -$6.55M |
|
20
Keros Therapeutics
KROS
$618M
| $10.5M | 0.9% | 328,781 -168,380 | -34% | -$5.37M |
|
21
Payoneer
PAYO
$2.5B
| $9.87M | 0.84% | 1,612,862 | – | – |
|
|
RDNW
22
RideNow Group, Inc. Class B Common Stock
RDNW
$147M
| $9.84M | 0.84% | 1,605,392 +334,041 | +26% | +$2.05M |
|
23
Abeona Therapeutics
ABEO
$350M
| $9.67M | 0.83% | 2,297,794 +895,914 | +64% | +$3.77M |
|
24
Codexis
CDXS
$246M
| $9.58M | 0.82% | 5,069,443 +33,780 | +0.7% | +$63.8K |
|
25
Amneal Pharmaceuticals
AMRX
$3B
| $9.34M | 0.8% | 2,212,757 +63,452 | +3% | +$268K |
|